|
1
|
Wakil SJ: Fatty-acid synthase, a
proficient multifunctional enzyme. Biochemistry. 28:4523–4530.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Milgraum LZ, Witters LA, Pasternack GR and
Kuhajda FP: Enzymes of the fatty acid synthesis pathway are highly
expressed in in situ breast carcinoma. Clin Cancer Res.
3:2115–2120. 1997.PubMed/NCBI
|
|
3
|
Aggarwal BB and Shishodia S: Molecular
targets of dietary agents for prevention and therapy of cancer.
Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alo' PL, Visca P, Marci A, Mangoni A,
Botti C and Di Tondo U: Expression of fatty acid synthase (FAS) as
a predictor of recurrence in stage I breast carcinoma patients.
Cancer. 77:474–482. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Swinnen JV, Roskams T, Joniau S, Van
Poppel H, Oyen R, Baert L, Heyns W and Verhoeven G: Overexpression
of fatty acid synthase is an early and common event in the
development of prostate cancer. Int J Cancer. 98:19–22. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pizer ES, Lax SF, Kuhajda FP, Pasternack
GR and Kurman RJ: Fatty acid synthase expression in endometrial
carcinoma: Correlation with cell proliferation and hormone
receptors. Cancer. 83:528–537. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gansler TS, Hardman W III, Hunt DA,
Schaffel S and Hennigar RA: Increased expression of fatty acid
synthase (OA-519) in ovarian neoplasms predicts shorter survival.
Hum Pathol. 28:686–692. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rashid A, Pizer ES, Moga M, Milgraum LZ,
Zahurak M, Pasternack GR, Kuhajda FP and Hamilton SR: Elevated
expression of fatty acid synthase and fatty acid synthetic activity
in colorectal neoplasia. Am J Pathol. 150:201–208. 1997.PubMed/NCBI
|
|
9
|
Orita H, Coulter J, Tully E, Kuhajda FP
and Gabrielson E: Inhibiting fatty acid synthase for
chemoprevention of chemically induced lung tumors. Clin Cancer Res.
14:2458–2464. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Nie F, Ouyang J, Wang X and Ma X:
Inhibitory effects of sea buckthorn procyanidins on fatty acid
synthase and MDA-MB-231 cells. Tumor Biol. 35:9563–9569. 2014.
View Article : Google Scholar
|
|
11
|
Alo PL, Amini M, Piro F, Pizzuti L,
Sebastiani V, Botti C, Murari R, Zotti G and Di Tondo U:
Immunohistochemical expression and prognostic significance of fatty
acid synthase in pancreatic carcinoma. Anticancer Res.
27:2523–2527. 2007.PubMed/NCBI
|
|
12
|
Fan H, Tian W and Ma X: Curcumin induces
apoptosis of HepG2 cells via inhibiting fatty acid synthase. Target
Oncol. 9:279–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Tian WX and Ma XF: Inhibitory
effects of onion (Allium cepa L.) extract on proliferation
of cancer cells and adipocytes via inhibiting fatty acid synthase.
Asian Pac J Cancer Prev. 13:5573–5579. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Walter K, Hong SM, Nyhan S, Canto M,
Fedarko N, Klein A, Griffith M, Omura N, Medghalchi S, Kuhajda F
and Goggins M: Serum fatty acid synthase as a marker of pancreatic
neoplasia. Cancer Epidemiol Biomarkers Prev. 18:2380–2385. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ginsburg OM and Love RR: Breast cancer: A
neglected disease for the majority of affected women worldwide.
Breast J. 17:289–295. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Swinnen JV, Heemers H, Deboel L, Foufelle
F, Heyns W and Verhoeven G: Stimulation of tumor-associated fatty
acid synthase expression by growth factor activation of the sterol
regulatory element-binding protein pathway. Oncogene. 19:5173–5181.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prieto-Hontoria PL, Pérez-Matute P,
Fernández-Galilea M, Bustos M, Martínez JA and Moreno-Aliaga MJ:
Role of obesity-associated dysfunctional adipose tissue in cancer:
A molecular nutrition approach. Biochim Biophys Acta. 1807:664–678.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuhajda FP: Fatty acid synthase and
cancer: New application of an old pathway. Cancer Res.
66:5977–5980. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li P, Tian W, Wang X and Ma X: Inhibitory
effect of desoxyrhaponticin and rhaponticin, two natural stilbene
glycosides from the Tibetan nutritional food Rheum
tanguticum Maxim. ex Balf., on fatty acid synthase and human
breast cancer cells. Food Funct. 5:251–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li P, Tian W and Ma X: Alpha-mangostin
inhibits intracellular fatty acid synthase and induces apoptosis in
breast cancer cells. Mol Cancer. 13:1382014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fan H, Wu D, Tian W and Ma X: Inhibitory
effects of tannic acid on fatty acid synthase and 3T3-L1
preadipocyte. Biochim Biophys Acta. 1831:1260–1266. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu D, Ma X and Tian W: Pomegranate husk
extract, punicalagin and ellagic acid inhibit fatty acid synthase
and adipogenesis of 3T3-L1 adipocyte. J Funct Food. 5:633–641.
2013. View Article : Google Scholar
|
|
23
|
Quan X, Wang Y, Ma X, Liang Y, Tian W, Ma
Q, Jiang H and Zhao Y: α-Mangostin induces apoptosis and suppresses
differentiation of 3T3-L1 cells via inhibiting fatty acid synthase.
PLoS One. 7:e333762012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang HZ, Ma QY, Fan HJ, Liang WJ, Huang
SZ, Dai HF, Wang PC, Ma XF and Zhao YX: Fatty acid synthase
inhibitors isolated from Punica granatum L. J Braz Chem Soc.
23:889–893. 2012. View Article : Google Scholar
|
|
25
|
Jiang HZ, Quan XF, Tian WX, Hu JM, Wang
PC, Huang SZ, Cheng ZQ, Liang WJ, Zhou J, Ma XF and Zhao YX: Fatty
acid synthase inhibitors of phenolic constituents isolated from
Garcinia mangostana. Bioorg Med Chem Lett. 20:6045–6047.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang Y, Tian W and Ma X: Inhibitory
effects of grape skin extract and resveratrol on fatty acid
synthase. BMC Complement Altern Med. 13:3612013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nie F, Liang Y, Xun H, Sun J, He F and Ma
X: Inhibitory effects of tannic acid in the early stage of 3T3-L1
preadipocytes differentiation by down-regulating PPARγ expression.
Food Funct. 6:894–901. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang B, Liang Y, Sun X, Liu X, Tian W and
Ma X: Potent inhibitory effect of chinese dietary spices on fatty
acid synthase. Plant Foods Hum Nutr. 70:257–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zeng XF, Li WW, Fan HJ, Wang XY, Pan J,
Wang ZR, Ma S, Li LL, Ma XF and Yang SY: Discovery of novel fatty
acid synthase (FAS) inhibitors based on the structure of ketoaceyl
synthase (KS) domain. Bioorg Med Chem Lett. 21:4742–4744. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao YX, Liang WJ, Fan HJ, Ma QY, Tian WX,
Dai HF, Jiang HZ, Li N and Ma XF: Fatty acid synthase inhibitors
from the hulls of Nephelium lappaceum L. Carbohydrate Res.
346:1302–1306. 2011. View Article : Google Scholar
|
|
31
|
Tian WX: Inhibition of fatty acid synthase
by polyphenols. Curr Med Chem. 13:967–977. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yasukawa K and Kasahara Y: Effects of
flavonoids from French marigold (Florets of Tagetes patula
L.) on acute inflammation model. Int J Inflam. 2013:3094932013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koleckar V, Brojerova E, Rehakova Z,
Kubikova K, Cervenka F, Kuca K, Jun D, Hronek M, Opletalova V and
Opletal L: In vitro antiplatelet activity of flavonoids from
Leuzea carthamoides. Drug Chem Toxicol. 31:27–35. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang JJ, Ye G, Chen WL and Zhao WM:
Antibacterial phenolic components from Eriocaulon
buergerianum. Phytochemistry. 69:1279–1286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Könczöl A, Engel R, Szabó K, Hornok K,
Tóth S, Béni Z, Prechl A, Máthé I and Balogh Tibor G: Topical
analgesic, anti-inflammatory and antioxidant properties of
Oxybaphus nyctagineus: Phytochemical characterization of
active fractions. J Ethnopharmacol. 155:776–784. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li S, Mao W, Cao X, Liang S, Ding Z and Li
N: Inhibition of rat lens aldose reductase by quercetagetin and
patuletin. Yan Ke Xue Bao. 7(29–30): 331991.
|
|
37
|
Yoon S, Lee MY, Park SW, Moon JS, Koh YK,
Ahn YH, Park BW and Kim KS: Up-regulation of acetyl-CoA carboxylase
alpha and fatty acid synthase by human epidermal growth factor
receptor 2 at the translational level in breast cancer cells. J
Biol Chem. 282:26122–26131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Uddin S, Ah-Kang J, Ulaszek J, Mahmud D
and Wickrema A: Differentiation stage-specific activation of p38
mitogen-activated protein kinase isoforms in primary human
erythroid cells. P Natl Acad Sci USA. 101:147–152. 2004. View Article : Google Scholar
|
|
39
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fan H, Liang Y, Jiang B, Li X, Xun H, Sun
J, He W, Lau HT and Ma X: Curcumin inhibits intracellular fatty
acid synthase and induces apoptosis in human breast cancer
MDA-MB-231 cells. Oncol Rep. 35:2651–2656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Adaramoye O, Erguen B, Nitzsche B, Höpfner
M, Jung K and Rabien A: Punicalagin, a polyphenol from pomegranate
fruit, induces growth inhibition and apoptosis in human PC-3 and
LNCaP cells. Chem Biol Interact. 274:100–106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Szeja W, Grynkiewicz G and Rusin A:
Isoflavones, their glycosides and glycoconjugates. synthesis and
biological activity. Curr Org Chem. 21:218–235. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Menendez JA, Mehmi I, Atlas E, Colomer R
and Lupu R: Novel signaling molecules implicated in
tumor-associated fatty acid synthase-dependent breast cancer cell
proliferation and survival: Role of exogenous dietary fatty acids,
p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1,
BRCA1, and NF-κB. Int J Oncol. 24:591–608. 2004.PubMed/NCBI
|
|
44
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cioccoloni G, Bonmassar L, Pagani E,
Caporali S, Fuggetta MP, Bonmassar E, D'Atri S and Aquino A:
Influence of fatty acid synthase inhibitor orlistat on the DNA
repair enzyme O6-methylguanine-DNA methyltransferase in human
normal or malignant cells in vitro. Int J Oncol. 47:764–772. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rae C, Haberkorn U, Babich JW and Mairs
RJ: Inhibition of fatty acid synthase sensitizes prostate cancer
cells to radiotherapy. Radiat Res. 184:482–493. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pizer ES, Thupari J, Han WF, Pinn ML,
Chrest FJ, Frehywot GL, Townsend CA and Kuhajda FP:
Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced
by fatty-acid synthase inhibition in human breast cancer cells and
xenografts. Cancer Res. 60:213–218. 2000.PubMed/NCBI
|
|
48
|
Zhou W, Simpson PJ, McFadden JM, Townsend
CA, Medghalchi SM, Vadlamudi A, Pinn ML, Ronnett GV and Kuhajda FP:
Fatty acid synthase inhibition triggers apoptosis during S phase in
human cancer cells. Cancer Res. 63:7330–7337. 2003.PubMed/NCBI
|
